
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
Click the link above to open The Column February 2022 Europe & Asia issue, Volume 18, Number 2, in an interactive PDF format.
almost 5 years ago
The Return of the HPLC Conferencealmost 5 years ago
My Career as a Separation Scientistalmost 5 years ago
Virtual Event Preview: EuSP2022 and GSAC2022almost 5 years ago
The LCGC Blog: Analyzing Trends of the Cannabis Testing Marketalmost 5 years ago
Lonza and Agilent Announce Cell Therapy Collaborationalmost 5 years ago
Illicit Drug Analysis Using GC–IMS and Oral Fluidsalmost 5 years ago
Thermo Fisher Announces PeproTech Acquisitionalmost 5 years ago
Markes International Sponsors “Forget Me Knot” Charity Expedition




